WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Complicated Urinary Tract Infections - Efficacy Framework v7, Study Drug | Comparator subjected to Susceptibility Testing, Study Drug | Comparator has value for Dosage, Microbiological Outcomes includes Indeterminate, Microbiologically Evaluable Population (ME) classified by Country/Region, Defined Time Point includes LTFU Visit, Microbiological Eradication Rate measured in Microbiological Intent to Treat Population (MITT), Microbiological Eradication Rate calculated by Microbiological Eradication Rate Formula, Disposition includes Randomized, Signs and Symptoms of cUTI and AP includes Malaise, Demographics includes Age, Ascending example Ascending Pyelonephritis, Demographics includes Sex, Route of Infection includes Ascending, Clinical Outcomes assessed at Defined Time Point, Demographics includes Height, Prematurely Withdrawn from Study includes Administrative Reasons, Study Drug | Comparator may be administered with Concomitant Antibiotic, Clinical Outcomes assessed for Patient, Defined Time Point includes EOT Visit, Patient can experience Type of Infection